Home Go to http://www.treatHIV.com
From the Podium HomeBoardAboutContact
 

Perspectives and OpinionsMutation and Drug DataAsk the ExpertsTest InfoFrom the PodiumDaily Resistance NewsBest of SiteArchive
Yellow arrow Question 6
  With respect to M184V and K103N, should physicians be trying to maintain these "beneficial" mutations?


Speaker Listen to the answer - Real Media®

Speaker Listen to the answer - Windows Media®

Newspaper Read this answer

Respondants

Blue arrow Mark A. Wainberg
Read Bio
Blue arrow Charles Boucher
Read Bio
Blue arrow David A. Katzenstien
Read Bio
Blue arrow Jonathan M. Schapiro
Read Bio


  Vertibrae
Copyright © 1997–2003, Vertibrae, Inc. and HIVresistanceWeb. All rights reserved.  |  Privacy Policy
RegisterLogin